Dr. Kavya Harika Dendukuri | Hepatology Specialist in Chennai | Dr. Rela Institute, India

Dr. Kavya Harika Dendukuri

MBBS, MD (Internal Medicine), DM, Post Doctoral Fellowship in Transplant

Consultant

Hepatology, Medical Gastroenterology

Chennai

Make An Appointment

Educational Qualifications

  • MBBS 2008, Mediciti Institute of Medical Sciences
  • MD Internal Medicine 2012, Navodaya Medical college hospital, Raichur, India
  • DM Medical Gastroenterology & Hepatology 2015, Sri Ramachandra University, Chennai- India.
  • PDF in Transplant Hepatology 2017, Global Health City, Chennai, India.
 

Experience

  • March 2017 to September 2018 Consultant Hepatologist, Global Health City, Chennai, India

Research & Publication

Posters:

  • Isolated Small Terminal Ileal Ulcers- Diagnostic Utility of Endoscopic Biopsies in MIDTERM ISGCON- 2014, Coimbatore. India.

Oral Presentations:

  • Presented a rare case of Hepatitis C at Singapore Hepatitis Conference- Best of EASL- May 2016.
  • Presented a case at a CME- February - 2016, Chennai, India.
  • Presented case series on Isolated Small Terminal Ileal Ulcers. Diagnostic Utility of Endoscopic Biopsies at MIDTERM ISGCON- 2014, Coimbatore
  • Presented a case of recurrent AIH in Post-transplant setting at MCLD, Jan-2017, Chennai.

Scientific Publications Published:

  • Kavya Harika Dendukuri, Shanti Vijayaraghavan. Isolated Small Terminal Ileal Ulcers- Diagnostic Utility of Endoscopic Biopsies. Journal of Evidence based Medicine and Health Care. Issue 30, July 27, 2015.
  • H Pavan, Joy V, Kavya Harika et al - Case Report on Malignant Hepatic EpitheloidHemangioendothelioma with Villaret syndrome- Journal of Clinical and Experimental Hepatology – September 28th 2016.
  • HRQL using SF36 (Generic Specific) in liver cirrhsosis – Indian Journal of Gastroentrology.
  • Cryptogenic cirrhosis - Mystery decoded on explant evaluation.
  • Explant liver opening a Pandora`s box.
  • Therapeutic plasma exchange as an adjuent to supportive management in ESLD patients with high MELD score > 25, awaiting Liver Transplantation. Journal of Clinical & Experimental Hepatology. 6(1); S36 July 2016
  • Combination of TACE & Sorafenib improve outcomes in BCLC stage B/C of Hepatocellular Carcinoma. A single centre Experience.
 

Get in Touch With Rela Institute

HAVE A QUESTION?

= ??

iPhone
Request a Callback Request a Callback
Request an Appointment Request an Appointment

Blog

All you need to know about Hepatitis C

All you need to know about Hepatitis C

Alcoholic Hepatitis - Learn how to prevent it

Alcoholic Hepatitis - Learn how to prevent it

To seek a quick appointment




Request a Callback Request a Callback

Request an AppointmentRequest an Appointment

QUICK LINKS

INSTITUTE

CLINICAL EXCELLENCE

ACCREDITATIONS

  • NABH
  • NABH Blood Bank
  • NABL

DEPARTMENTS


ABOUT US

ACADEMICS

CAREERS

INTERNATIONAL PATIENTS

MEDIA

PATIENT CARE

HEALTH CHECK

SUCCESS STORIES

PATIENT RESOURCES

EXPERT TALK

WELLNESS NETWORK

ONLINE PAYMENT

FEEDBACK

CONTACT US
Terms and Conditions | Cancellation and Refund Policy | Privacy Policy | Disclaimer
Copyrights © 2021 Rela Institute & Medical Centre. All Rights Reserved.

Make an Appointment

Make an Appointment

Find a Doctor

Find a Doctor

Ask Second Opinion

Expert Opinion

Get Your Lab Reports

Lab Reports

Request a Call Back

Request a Callback

Get in Touch With Rela Institute

Have a Question?